カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界の皮膚疾患治療薬市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Dermatological Disorders Medications Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO19261）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO19261
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：109
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界の皮膚疾患治療薬市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

皮膚疾患治療薬市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界の皮膚疾患治療薬の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

皮膚疾患治療薬市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・処方薬、一般用医薬品

用途別セグメントは次のように区分されます。
・病院薬局、オンライン薬局、リテール薬局

世界の皮膚疾患治療薬市場の主要な市場プレーヤーは以下のとおりです。
・Mylan Pharmaceuticals、Pfizer、Roche、Almirall、Bausch Health、Barrier Therapeutics、PharmaDerm、Bristol-Myers Squibb、Galderma、GlaxoSmithKline、Novartis、Sinclair Pharma

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、皮膚疾患治療薬製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な皮膚疾患治療薬メーカーの企業概要、2019年～2022年までの皮膚疾患治療薬の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な皮膚疾患治療薬メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別皮膚疾患治療薬の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までの皮膚疾患治療薬の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での皮膚疾患治療薬市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および皮膚疾患治療薬の産業チェーンを掲載しています。
・第13、14、15章では、皮膚疾患治療薬の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- 皮膚疾患治療薬の概要
- 種類別分析（2017年vs2021年vs2028年）：処方薬、一般用医薬品
- 用途別分析（2017年vs2021年vs2028年）：病院薬局、オンライン薬局、リテール薬局
- 世界の皮膚疾患治療薬市場規模・予測
- 世界の皮膚疾患治療薬生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Mylan Pharmaceuticals、Pfizer、Roche、Almirall、Bausch Health、Barrier Therapeutics、PharmaDerm、Bristol-Myers Squibb、Galderma、GlaxoSmithKline、Novartis、Sinclair Pharma
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：処方薬、一般用医薬品
・用途別分析2017年-2028年：病院薬局、オンライン薬局、リテール薬局
・皮膚疾患治療薬の北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・皮膚疾患治療薬のヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・皮膚疾患治療薬のアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・皮膚疾患治療薬の南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・皮膚疾患治療薬の中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Dermatological Disorders Medications market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Dermatological Disorders Medications market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospital Pharmacies accounting for % of the Dermatological Disorders Medications global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Prescription Drugs segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Dermatological Disorders Medications include Mylan Pharmaceuticals, Pfizer, Roche, Almirall, and Bausch Health, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Dermatological Disorders Medications market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Prescription Drugs
Over-The-Counter Drugs
Market segment by Application can be divided into
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
The key market players for global Dermatological Disorders Medications market are listed below:
Mylan Pharmaceuticals
Pfizer
Roche
Almirall
Bausch Health
Barrier Therapeutics
PharmaDerm
Bristol-Myers Squibb
Galderma
GlaxoSmithKline
Novartis
Sinclair Pharma
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Dermatological Disorders Medications product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Dermatological Disorders Medications, with price, sales, revenue and global market share of Dermatological Disorders Medications from 2019 to 2022.
Chapter 3, the Dermatological Disorders Medications competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Dermatological Disorders Medications breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Dermatological Disorders Medications market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Dermatological Disorders Medications.
Chapter 13, 14, and 15, to describe Dermatological Disorders Medications sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Dermatological Disorders Medications Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Dermatological Disorders Medications Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Prescription Drugs
1.2.3 Over-The-Counter Drugs
1.3 Market Analysis by Application
1.3.1 Overview: Global Dermatological Disorders Medications Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital Pharmacies
1.3.3 Online Pharmacies
1.3.4 Retail Pharmacies
1.4 Global Dermatological Disorders Medications Market Size & Forecast
1.4.1 Global Dermatological Disorders Medications Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Dermatological Disorders Medications Sales in Volume (2017-2028)
1.4.3 Global Dermatological Disorders Medications Price (2017-2028)
1.5 Global Dermatological Disorders Medications Production Capacity Analysis
1.5.1 Global Dermatological Disorders Medications Total Production Capacity (2017-2028)
1.5.2 Global Dermatological Disorders Medications Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Dermatological Disorders Medications Market Drivers
1.6.2 Dermatological Disorders Medications Market Restraints
1.6.3 Dermatological Disorders Medications Trends Analysis
2 Manufacturers Profiles
2.1 Mylan Pharmaceuticals
2.1.1 Mylan Pharmaceuticals Details
2.1.2 Mylan Pharmaceuticals Major Business
2.1.3 Mylan Pharmaceuticals Dermatological Disorders Medications Product and Services
2.1.4 Mylan Pharmaceuticals Dermatological Disorders Medications Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Pfizer
2.2.1 Pfizer Details
2.2.2 Pfizer Major Business
2.2.3 Pfizer Dermatological Disorders Medications Product and Services
2.2.4 Pfizer Dermatological Disorders Medications Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Roche
2.3.1 Roche Details
2.3.2 Roche Major Business
2.3.3 Roche Dermatological Disorders Medications Product and Services
2.3.4 Roche Dermatological Disorders Medications Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Almirall
2.4.1 Almirall Details
2.4.2 Almirall Major Business
2.4.3 Almirall Dermatological Disorders Medications Product and Services
2.4.4 Almirall Dermatological Disorders Medications Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Bausch Health
2.5.1 Bausch Health Details
2.5.2 Bausch Health Major Business
2.5.3 Bausch Health Dermatological Disorders Medications Product and Services
2.5.4 Bausch Health Dermatological Disorders Medications Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Barrier Therapeutics
2.6.1 Barrier Therapeutics Details
2.6.2 Barrier Therapeutics Major Business
2.6.3 Barrier Therapeutics Dermatological Disorders Medications Product and Services
2.6.4 Barrier Therapeutics Dermatological Disorders Medications Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 PharmaDerm
2.7.1 PharmaDerm Details
2.7.2 PharmaDerm Major Business
2.7.3 PharmaDerm Dermatological Disorders Medications Product and Services
2.7.4 PharmaDerm Dermatological Disorders Medications Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Bristol-Myers Squibb
2.8.1 Bristol-Myers Squibb Details
2.8.2 Bristol-Myers Squibb Major Business
2.8.3 Bristol-Myers Squibb Dermatological Disorders Medications Product and Services
2.8.4 Bristol-Myers Squibb Dermatological Disorders Medications Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Galderma
2.9.1 Galderma Details
2.9.2 Galderma Major Business
2.9.3 Galderma Dermatological Disorders Medications Product and Services
2.9.4 Galderma Dermatological Disorders Medications Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 GlaxoSmithKline
2.10.1 GlaxoSmithKline Details
2.10.2 GlaxoSmithKline Major Business
2.10.3 GlaxoSmithKline Dermatological Disorders Medications Product and Services
2.10.4 GlaxoSmithKline Dermatological Disorders Medications Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Novartis
2.11.1 Novartis Details
2.11.2 Novartis Major Business
2.11.3 Novartis Dermatological Disorders Medications Product and Services
2.11.4 Novartis Dermatological Disorders Medications Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Sinclair Pharma
2.12.1 Sinclair Pharma Details
2.12.2 Sinclair Pharma Major Business
2.12.3 Sinclair Pharma Dermatological Disorders Medications Product and Services
2.12.4 Sinclair Pharma Dermatological Disorders Medications Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Dermatological Disorders Medications Breakdown Data by Manufacturer
3.1 Global Dermatological Disorders Medications Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Dermatological Disorders Medications Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Dermatological Disorders Medications
3.4 Market Concentration Rate
3.4.1 Top 3 Dermatological Disorders Medications Manufacturer Market Share in 2021
3.4.2 Top 6 Dermatological Disorders Medications Manufacturer Market Share in 2021
3.5 Global Dermatological Disorders Medications Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Dermatological Disorders Medications Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Dermatological Disorders Medications Market Size by Region
4.1.1 Global Dermatological Disorders Medications Sales in Volume by Region (2017-2028)
4.1.2 Global Dermatological Disorders Medications Revenue by Region (2017-2028)
4.2 North America Dermatological Disorders Medications Revenue (2017-2028)
4.3 Europe Dermatological Disorders Medications Revenue (2017-2028)
4.4 Asia-Pacific Dermatological Disorders Medications Revenue (2017-2028)
4.5 South America Dermatological Disorders Medications Revenue (2017-2028)
4.6 Middle East and Africa Dermatological Disorders Medications Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Dermatological Disorders Medications Sales in Volume by Type (2017-2028)
5.2 Global Dermatological Disorders Medications Revenue by Type (2017-2028)
5.3 Global Dermatological Disorders Medications Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Dermatological Disorders Medications Sales in Volume by Application (2017-2028)
6.2 Global Dermatological Disorders Medications Revenue by Application (2017-2028)
6.3 Global Dermatological Disorders Medications Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Dermatological Disorders Medications Sales by Type (2017-2028)
7.2 North America Dermatological Disorders Medications Sales by Application (2017-2028)
7.3 North America Dermatological Disorders Medications Market Size by Country
7.3.1 North America Dermatological Disorders Medications Sales in Volume by Country (2017-2028)
7.3.2 North America Dermatological Disorders Medications Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Dermatological Disorders Medications Sales by Type (2017-2028)
8.2 Europe Dermatological Disorders Medications Sales by Application (2017-2028)
8.3 Europe Dermatological Disorders Medications Market Size by Country
8.3.1 Europe Dermatological Disorders Medications Sales in Volume by Country (2017-2028)
8.3.2 Europe Dermatological Disorders Medications Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Dermatological Disorders Medications Sales by Type (2017-2028)
9.2 Asia-Pacific Dermatological Disorders Medications Sales by Application (2017-2028)
9.3 Asia-Pacific Dermatological Disorders Medications Market Size by Region
9.3.1 Asia-Pacific Dermatological Disorders Medications Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Dermatological Disorders Medications Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Dermatological Disorders Medications Sales by Type (2017-2028)
10.2 South America Dermatological Disorders Medications Sales by Application (2017-2028)
10.3 South America Dermatological Disorders Medications Market Size by Country
10.3.1 South America Dermatological Disorders Medications Sales in Volume by Country (2017-2028)
10.3.2 South America Dermatological Disorders Medications Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Dermatological Disorders Medications Sales by Type (2017-2028)
11.2 Middle East & Africa Dermatological Disorders Medications Sales by Application (2017-2028)
11.3 Middle East & Africa Dermatological Disorders Medications Market Size by Country
11.3.1 Middle East & Africa Dermatological Disorders Medications Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Dermatological Disorders Medications Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Dermatological Disorders Medications and Key Manufacturers
12.2 Manufacturing Costs Percentage of Dermatological Disorders Medications
12.3 Dermatological Disorders Medications Production Process
12.4 Dermatological Disorders Medications Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Dermatological Disorders Medications Typical Distributors
13.3 Dermatological Disorders Medications Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Dermatological Disorders Medications Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Dermatological Disorders Medications Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Mylan Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 4. Mylan Pharmaceuticals Major Business
Table 5. Mylan Pharmaceuticals Dermatological Disorders Medications Product and Services
Table 6. Mylan Pharmaceuticals Dermatological Disorders Medications Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Pfizer Basic Information, Manufacturing Base and Competitors
Table 8. Pfizer Major Business
Table 9. Pfizer Dermatological Disorders Medications Product and Services
Table 10. Pfizer Dermatological Disorders Medications Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Roche Basic Information, Manufacturing Base and Competitors
Table 12. Roche Major Business
Table 13. Roche Dermatological Disorders Medications Product and Services
Table 14. Roche Dermatological Disorders Medications Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Almirall Basic Information, Manufacturing Base and Competitors
Table 16. Almirall Major Business
Table 17. Almirall Dermatological Disorders Medications Product and Services
Table 18. Almirall Dermatological Disorders Medications Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Bausch Health Basic Information, Manufacturing Base and Competitors
Table 20. Bausch Health Major Business
Table 21. Bausch Health Dermatological Disorders Medications Product and Services
Table 22. Bausch Health Dermatological Disorders Medications Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Barrier Therapeutics Basic Information, Manufacturing Base and Competitors
Table 24. Barrier Therapeutics Major Business
Table 25. Barrier Therapeutics Dermatological Disorders Medications Product and Services
Table 26. Barrier Therapeutics Dermatological Disorders Medications Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. PharmaDerm Basic Information, Manufacturing Base and Competitors
Table 28. PharmaDerm Major Business
Table 29. PharmaDerm Dermatological Disorders Medications Product and Services
Table 30. PharmaDerm Dermatological Disorders Medications Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 32. Bristol-Myers Squibb Major Business
Table 33. Bristol-Myers Squibb Dermatological Disorders Medications Product and Services
Table 34. Bristol-Myers Squibb Dermatological Disorders Medications Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Galderma Basic Information, Manufacturing Base and Competitors
Table 36. Galderma Major Business
Table 37. Galderma Dermatological Disorders Medications Product and Services
Table 38. Galderma Dermatological Disorders Medications Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 40. GlaxoSmithKline Major Business
Table 41. GlaxoSmithKline Dermatological Disorders Medications Product and Services
Table 42. GlaxoSmithKline Dermatological Disorders Medications Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Novartis Basic Information, Manufacturing Base and Competitors
Table 44. Novartis Major Business
Table 45. Novartis Dermatological Disorders Medications Product and Services
Table 46. Novartis Dermatological Disorders Medications Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Sinclair Pharma Basic Information, Manufacturing Base and Competitors
Table 48. Sinclair Pharma Major Business
Table 49. Sinclair Pharma Dermatological Disorders Medications Product and Services
Table 50. Sinclair Pharma Dermatological Disorders Medications Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Global Dermatological Disorders Medications Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 52. Global Dermatological Disorders Medications Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 53. Market Position of Manufacturers in Dermatological Disorders Medications, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 54. Global Dermatological Disorders Medications Production Capacity by Company, (K Units): 2020 VS 2021
Table 55. Head Office and Dermatological Disorders Medications Production Site of Key Manufacturer
Table 56. Dermatological Disorders Medications New Entrant and Capacity Expansion Plans
Table 57. Dermatological Disorders Medications Mergers & Acquisitions in the Past Five Years
Table 58. Global Dermatological Disorders Medications Sales by Region (2017-2022) & (K Units)
Table 59. Global Dermatological Disorders Medications Sales by Region (2023-2028) & (K Units)
Table 60. Global Dermatological Disorders Medications Revenue by Region (2017-2022) & (USD Million)
Table 61. Global Dermatological Disorders Medications Revenue by Region (2023-2028) & (USD Million)
Table 62. Global Dermatological Disorders Medications Sales by Type (2017-2022) & (K Units)
Table 63. Global Dermatological Disorders Medications Sales by Type (2023-2028) & (K Units)
Table 64. Global Dermatological Disorders Medications Revenue by Type (2017-2022) & (USD Million)
Table 65. Global Dermatological Disorders Medications Revenue by Type (2023-2028) & (USD Million)
Table 66. Global Dermatological Disorders Medications Price by Type (2017-2022) & (USD/Unit)
Table 67. Global Dermatological Disorders Medications Price by Type (2023-2028) & (USD/Unit)
Table 68. Global Dermatological Disorders Medications Sales by Application (2017-2022) & (K Units)
Table 69. Global Dermatological Disorders Medications Sales by Application (2023-2028) & (K Units)
Table 70. Global Dermatological Disorders Medications Revenue by Application (2017-2022) & (USD Million)
Table 71. Global Dermatological Disorders Medications Revenue by Application (2023-2028) & (USD Million)
Table 72. Global Dermatological Disorders Medications Price by Application (2017-2022) & (USD/Unit)
Table 73. Global Dermatological Disorders Medications Price by Application (2023-2028) & (USD/Unit)
Table 74. North America Dermatological Disorders Medications Sales by Country (2017-2022) & (K Units)
Table 75. North America Dermatological Disorders Medications Sales by Country (2023-2028) & (K Units)
Table 76. North America Dermatological Disorders Medications Revenue by Country (2017-2022) & (USD Million)
Table 77. North America Dermatological Disorders Medications Revenue by Country (2023-2028) & (USD Million)
Table 78. North America Dermatological Disorders Medications Sales by Type (2017-2022) & (K Units)
Table 79. North America Dermatological Disorders Medications Sales by Type (2023-2028) & (K Units)
Table 80. North America Dermatological Disorders Medications Sales by Application (2017-2022) & (K Units)
Table 81. North America Dermatological Disorders Medications Sales by Application (2023-2028) & (K Units)
Table 82. Europe Dermatological Disorders Medications Sales by Country (2017-2022) & (K Units)
Table 83. Europe Dermatological Disorders Medications Sales by Country (2023-2028) & (K Units)
Table 84. Europe Dermatological Disorders Medications Revenue by Country (2017-2022) & (USD Million)
Table 85. Europe Dermatological Disorders Medications Revenue by Country (2023-2028) & (USD Million)
Table 86. Europe Dermatological Disorders Medications Sales by Type (2017-2022) & (K Units)
Table 87. Europe Dermatological Disorders Medications Sales by Type (2023-2028) & (K Units)
Table 88. Europe Dermatological Disorders Medications Sales by Application (2017-2022) & (K Units)
Table 89. Europe Dermatological Disorders Medications Sales by Application (2023-2028) & (K Units)
Table 90. Asia-Pacific Dermatological Disorders Medications Sales by Region (2017-2022) & (K Units)
Table 91. Asia-Pacific Dermatological Disorders Medications Sales by Region (2023-2028) & (K Units)
Table 92. Asia-Pacific Dermatological Disorders Medications Revenue by Region (2017-2022) & (USD Million)
Table 93. Asia-Pacific Dermatological Disorders Medications Revenue by Region (2023-2028) & (USD Million)
Table 94. Asia-Pacific Dermatological Disorders Medications Sales by Type (2017-2022) & (K Units)
Table 95. Asia-Pacific Dermatological Disorders Medications Sales by Type (2023-2028) & (K Units)
Table 96. Asia-Pacific Dermatological Disorders Medications Sales by Application (2017-2022) & (K Units)
Table 97. Asia-Pacific Dermatological Disorders Medications Sales by Application (2023-2028) & (K Units)
Table 98. South America Dermatological Disorders Medications Sales by Country (2017-2022) & (K Units)
Table 99. South America Dermatological Disorders Medications Sales by Country (2023-2028) & (K Units)
Table 100. South America Dermatological Disorders Medications Revenue by Country (2017-2022) & (USD Million)
Table 101. South America Dermatological Disorders Medications Revenue by Country (2023-2028) & (USD Million)
Table 102. South America Dermatological Disorders Medications Sales by Type (2017-2022) & (K Units)
Table 103. South America Dermatological Disorders Medications Sales by Type (2023-2028) & (K Units)
Table 104. South America Dermatological Disorders Medications Sales by Application (2017-2022) & (K Units)
Table 105. South America Dermatological Disorders Medications Sales by Application (2023-2028) & (K Units)
Table 106. Middle East & Africa Dermatological Disorders Medications Sales by Region (2017-2022) & (K Units)
Table 107. Middle East & Africa Dermatological Disorders Medications Sales by Region (2023-2028) & (K Units)
Table 108. Middle East & Africa Dermatological Disorders Medications Revenue by Region (2017-2022) & (USD Million)
Table 109. Middle East & Africa Dermatological Disorders Medications Revenue by Region (2023-2028) & (USD Million)
Table 110. Middle East & Africa Dermatological Disorders Medications Sales by Type (2017-2022) & (K Units)
Table 111. Middle East & Africa Dermatological Disorders Medications Sales by Type (2023-2028) & (K Units)
Table 112. Middle East & Africa Dermatological Disorders Medications Sales by Application (2017-2022) & (K Units)
Table 113. Middle East & Africa Dermatological Disorders Medications Sales by Application (2023-2028) & (K Units)
Table 114. Dermatological Disorders Medications Raw Material
Table 115. Key Manufacturers of Dermatological Disorders Medications Raw Materials
Table 116. Direct Channel Pros & Cons
Table 117. Indirect Channel Pros & Cons
Table 118. Dermatological Disorders Medications Typical Distributors
Table 119. Dermatological Disorders Medications Typical Customers
List of Figures
Figure 1. Dermatological Disorders Medications Picture
Figure 2. Global Dermatological Disorders Medications Revenue Market Share by Type in 2021
Figure 3. Prescription Drugs
Figure 4. Over-The-Counter Drugs
Figure 5. Global Dermatological Disorders Medications Revenue Market Share by Application in 2021
Figure 6. Hospital Pharmacies
Figure 7. Online Pharmacies
Figure 8. Retail Pharmacies
Figure 9. Global Dermatological Disorders Medications Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 10. Global Dermatological Disorders Medications Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global Dermatological Disorders Medications Sales (2017-2028) & (K Units)
Figure 12. Global Dermatological Disorders Medications Price (2017-2028) & (USD/Unit)
Figure 13. Global Dermatological Disorders Medications Production Capacity (2017-2028) & (K Units)
Figure 14. Global Dermatological Disorders Medications Production Capacity by Geographic Region: 2022 VS 2028
Figure 15. Dermatological Disorders Medications Market Drivers
Figure 16. Dermatological Disorders Medications Market Restraints
Figure 17. Dermatological Disorders Medications Market Trends
Figure 18. Global Dermatological Disorders Medications Sales Market Share by Manufacturer in 2021
Figure 19. Global Dermatological Disorders Medications Revenue Market Share by Manufacturer in 2021
Figure 20. Dermatological Disorders Medications Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 21. Top 3 Dermatological Disorders Medications Manufacturer (Revenue) Market Share in 2021
Figure 22. Top 6 Dermatological Disorders Medications Manufacturer (Revenue) Market Share in 2021
Figure 23. Global Dermatological Disorders Medications Sales Market Share by Region (2017-2028)
Figure 24. Global Dermatological Disorders Medications Revenue Market Share by Region (2017-2028)
Figure 25. North America Dermatological Disorders Medications Revenue (2017-2028) & (USD Million)
Figure 26. Europe Dermatological Disorders Medications Revenue (2017-2028) & (USD Million)
Figure 27. Asia-Pacific Dermatological Disorders Medications Revenue (2017-2028) & (USD Million)
Figure 28. South America Dermatological Disorders Medications Revenue (2017-2028) & (USD Million)
Figure 29. Middle East & Africa Dermatological Disorders Medications Revenue (2017-2028) & (USD Million)
Figure 30. Global Dermatological Disorders Medications Sales Market Share by Type (2017-2028)
Figure 31. Global Dermatological Disorders Medications Revenue Market Share by Type (2017-2028)
Figure 32. Global Dermatological Disorders Medications Price by Type (2017-2028) & (USD/Unit)
Figure 33. Global Dermatological Disorders Medications Sales Market Share by Application (2017-2028)
Figure 34. Global Dermatological Disorders Medications Revenue Market Share by Application (2017-2028)
Figure 35. Global Dermatological Disorders Medications Price by Application (2017-2028) & (USD/Unit)
Figure 36. North America Dermatological Disorders Medications Sales Market Share by Type (2017-2028)
Figure 37. North America Dermatological Disorders Medications Sales Market Share by Application (2017-2028)
Figure 38. North America Dermatological Disorders Medications Sales Market Share by Country (2017-2028)
Figure 39. North America Dermatological Disorders Medications Revenue Market Share by Country (2017-2028)
Figure 40. United States Dermatological Disorders Medications Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Canada Dermatological Disorders Medications Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Mexico Dermatological Disorders Medications Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Europe Dermatological Disorders Medications Sales Market Share by Type (2017-2028)
Figure 44. Europe Dermatological Disorders Medications Sales Market Share by Application (2017-2028)
Figure 45. Europe Dermatological Disorders Medications Sales Market Share by Country (2017-2028)
Figure 46. Europe Dermatological Disorders Medications Revenue Market Share by Country (2017-2028)
Figure 47. Germany Dermatological Disorders Medications Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. France Dermatological Disorders Medications Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. United Kingdom Dermatological Disorders Medications Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Russia Dermatological Disorders Medications Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Italy Dermatological Disorders Medications Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Asia-Pacific Dermatological Disorders Medications Sales Market Share by Region (2017-2028)
Figure 53. Asia-Pacific Dermatological Disorders Medications Sales Market Share by Application (2017-2028)
Figure 54. Asia-Pacific Dermatological Disorders Medications Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Dermatological Disorders Medications Revenue Market Share by Region (2017-2028)
Figure 56. China Dermatological Disorders Medications Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Japan Dermatological Disorders Medications Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Korea Dermatological Disorders Medications Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. India Dermatological Disorders Medications Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Southeast Asia Dermatological Disorders Medications Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Australia Dermatological Disorders Medications Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. South America Dermatological Disorders Medications Sales Market Share by Type (2017-2028)
Figure 63. South America Dermatological Disorders Medications Sales Market Share by Application (2017-2028)
Figure 64. South America Dermatological Disorders Medications Sales Market Share by Country (2017-2028)
Figure 65. South America Dermatological Disorders Medications Revenue Market Share by Country (2017-2028)
Figure 66. Brazil Dermatological Disorders Medications Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Argentina Dermatological Disorders Medications Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Middle East & Africa Dermatological Disorders Medications Sales Market Share by Type (2017-2028)
Figure 69. Middle East & Africa Dermatological Disorders Medications Sales Market Share by Application (2017-2028)
Figure 70. Middle East & Africa Dermatological Disorders Medications Sales Market Share by Region (2017-2028)
Figure 71. Middle East & Africa Dermatological Disorders Medications Revenue Market Share by Region (2017-2028)
Figure 72. Turkey Dermatological Disorders Medications Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Egypt Dermatological Disorders Medications Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Saudi Arabia Dermatological Disorders Medications Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. South Africa Dermatological Disorders Medications Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Manufacturing Cost Structure Analysis of Dermatological Disorders Medications in 2021
Figure 77. Manufacturing Process Analysis of Dermatological Disorders Medications
Figure 78. Dermatological Disorders Medications Industrial Chain
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界の皮膚科治療オゾン療法ユニット市場2022年：市場規模予測（～2028年）
  • 皮膚科治療の世界市場 2022年-2026年
  • 世界のOTC鎮痛剤市場2022年：市場規模予測（～2028年）
  • 世界の関節炎治療用処方薬市場2022年：市場規模予測（～2028年）
  • 皮膚科治療用オゾン治療ユニットの世界市場2023年：デスクトップ型、携帯型
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO19261 )"世界の皮膚疾患治療薬市場2022年：市場規模予測（～2028年）" (英文：Global Dermatological Disorders Medications Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。